Cargando…

Long-term Outcomes of Lower Rectal Cancer Patients Treated with Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection after Preoperative Radiotherapy or Chemoradiotherapy

OBJECTIVES: The standard strategy for advanced rectal cancer (RC) is preoperative short-course radiotherapy (SCRT)/chemoradiotherapy (CRT) plus total mesorectal excision (TME) in Western countries; however, the survival benefit of adding chemotherapy to radiotherapy remains unclear. There is accumul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sakamoto, Wataru, Ohki, Shinji, Onozawa, Hisashi, Okayama, Hirokazu, Endo, Hisahito, Fujita, Shotaro, Saito, Motonobu, Saze, Zenichiro, Momma, Tomoyuki, Takenoshita, Seiichi, Kono, Koji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japan Society of Coloproctology 2021
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084532/ https://www.ncbi.nlm.nih.gov/pubmed/33937552 http://dx.doi.org/10.23922/jarc.2020-054

Ejemplares similares

Short-term outcomes of neoadjuvant chemotherapy with capecitabine plus oxaliplatin for patients with locally advanced rectal cancer followed by total or tumor-specific mesorectal excision with or without lateral pelvic lymph node dissection
por: Sakamoto, Wataru, et al.
Publicado: (2022)

Higher modified Glasgow Prognostic Score and multiple stapler firings for rectal transection are risk factors for anastomotic leakage after low anterior resection in rectal cancer
por: Sakamoto, Wataru, et al.
Publicado: (2020)

Microanatomy of inferior mesenteric artery sheath in colorectal cancer surgery
por: Sakamoto, Wataru, et al.
Publicado: (2019)

Validation of Gene Expression-Based Predictive Biomarkers for Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Momma, Tomoyuki, et al.
Publicado: (2021)

A subset of patients with MSS/MSI-low-colorectal cancer showed increased CD8(+) TILs together with up-regulated IFN-γ
por: Kikuchi, Tomohiro, et al.
Publicado: (2019)

Tuberculous peritonitis; The effectiveness of diagnostic laparoscopy and the perioperative infectious prevention: A case report
por: Yamada, Leo, et al.
Publicado: (2020)

PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms
por: Nakano, Hiroshi, et al.
Publicado: (2021)

Tn Antigen Expression Defines an Immune Cold Subset of Mismatch-Repair Deficient Colorectal Cancer
por: Matsumoto, Takuro, et al.
Publicado: (2020)

Incidence of upper extremity deep vein thrombosis in the retrosternal reconstruction after esophagectomy
por: Yamada, Leo, et al.
Publicado: (2022)

The Impact of Tumor Cell-Intrinsic Expression of Cyclic GMP-AMP Synthase (cGAS)-Stimulator of Interferon Genes (STING) on the Infiltration of CD8(+) T Cells and Clinical Outcomes in Mismatch Repair Proficient/Microsatellite Stable Colorectal Cancer
por: Nakajima, Shotaro, et al.
Publicado: (2023)

Downregulation of PAICS due to loss of chromosome 4q is associated with poor survival in stage III colorectal cancer
por: Kobayashi, Yusuke, et al.
Publicado: (2021)

Prognostic role of ARID1A negative expression in gastric cancer
por: Ashizawa, Mai, et al.
Publicado: (2019)

TIM-3 Expression and M2 Polarization of Macrophages in the TGFβ-Activated Tumor Microenvironment in Colorectal Cancer
por: Katagata, Masanori, et al.
Publicado: (2023)

Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer
por: Noda, Masaru, et al.
Publicado: (2018)

Upregulated HOXA9 expression is associated with lymph node metastasis in colorectal cancer
por: Watanabe, Yohei, et al.
Publicado: (2018)

A Potential Biomarker of Dynamic Change in Peripheral CD45RA(−)CD27(+)CD127(+) Central Memory T Cells for Anti-PD-1 Therapy in Patients with Esophageal Squamous Cell Carcinoma
por: Sakuma, Mei, et al.
Publicado: (2023)

Enhanced expression of KIF4A in colorectal cancer is associated with lymph node metastasis
por: Matsumoto, Yoshiko, et al.
Publicado: (2018)

Upregulated solute carrier family 37 member 1 in colorectal cancer is associated with poor patient outcome and metastasis
por: Kikuchi, Daiki, et al.
Publicado: (2018)

Expression of circadian clock genes in human colorectal adenoma and carcinoma
por: Momma, Tomoyuki, et al.
Publicado: (2017)

Systemic inflammation score as a preoperative prognostic factor for patients with pT2–T4 resectable gastric cancer: a retrospective study
por: Matsumoto, Takuro, et al.
Publicado: (2023)

The effects of T-DXd on the expression of HLA class I and chemokines CXCL9/10/11 in HER2-overexpressing gastric cancer cells
por: Nakajima, Shotaro, et al.
Publicado: (2021)

Stromal expression of cancer-associated fibroblast-related molecules, versican and lumican, is strongly associated with worse relapse-free and overall survival times in patients with esophageal squamous cell carcinoma
por: Yamauchi, Naoto, et al.
Publicado: (2021)

Epithelial‐mesenchymal transition‐converted tumor cells can induce T‐cell apoptosis through upregulation of programmed death ligand 1 expression in esophageal squamous cell carcinoma
por: Thar Min, Aung Kyi, et al.
Publicado: (2018)

Immunogenic tumor cell death induced by chemotherapy in patients with breast cancer and esophageal squamous cell carcinoma
por: Aoto, Keita, et al.
Publicado: (2018)

Introduction to Total Mesorectal Excision
por: Delibegovic, Samir
Publicado: (2017)

Clinical outcomes of laparoscopic and endoscopic cooperative surgery for gastric gastrointestinal stromal tumor
por: Hanayama, Hiroyuki, et al.
Publicado: (2022)

Local Excision ± Chemoradiotherapy vs. Total Mesorectal Excision for Early Rectal Cancer: Case-Matched Analysis of Long-Term Results
por: Pacevicius, Julius, et al.
Publicado: (2021)

Functional benefits of the double flap technique after proximal gastrectomy for gastric cancer
por: Saze, Zenichiro, et al.
Publicado: (2021)

Laparoscopic Proctocolectomy With Transanal Total Mesorectal Excision for Ulcerative Colitis
por: Ashitomi, Yuya, et al.
Publicado: (2021)

Urinary dysfunction in women following total mesorectal excision versus partial mesorectal excision for treatment of rectal cancer
por: Chill, Henry H., et al.
Publicado: (2021)

Required distal mesorectal resection margin in partial mesorectal excision: a systematic review on distal mesorectal spread
por: Grüter, A. A. J., et al.
Publicado: (2022)

Future directions in combined modality therapy for rectal cancer: reevaluating the role of total mesorectal excision after chemoradiotherapy
por: Solanki, Abhishek A, et al.
Publicado: (2013)

Universalization of the operative strategy by systematic mesogastric excision for stomach cancer with that for total mesorectal excision and complete mesocolic excision colorectal counterparts
por: Shinohara, Hisashi, et al.
Publicado: (2017)

Total mesorectal excision for the treatment of rectal cancer
por: Zedan, Ali, et al.
Publicado: (2015)

Transanal total mesorectal excision: Myths and reality
por: Buchs, Nicolas C, et al.
Publicado: (2016)

Timing of additional neoadjuvant chemotherapy in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy and total mesorectal excision
por: He, Fang, et al.
Publicado: (2022)

The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study
por: Akgun, Erhan, et al.
Publicado: (2017)

Transanal total mesorectal excision (TATME) – preliminary findings
por: Piątkowski, Jacek, et al.
Publicado: (2015)

Robotic total mesorectal excision for the treatment of rectal cancer
por: Baik, Seung Hyuk, et al.
Publicado: (2007)

Robotic transanal total mesorectal excision: Is the future now?
por: Sebastián-Tomás, Juan Carlos, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_mmf93u5dta1lit586uisualj6c